Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Oct 5, 2020 10:00 AM ET

Global Amino Acid Metabolism Disorders Treatment Market Set for Rapid Growth, to reach Value around USD 1,075.51 Million by 2025


iCrowd Newswire - Oct 5, 2020

Zion Market Research has published a new report titled “Amino Acid Metabolism Disorders Treatment Market by Indication (Argininosuccinic academia, Citrullinemia, Homocystinuria, Phenylketonuria and Maple syrup urine disease), Product (Arginine, Betaine, Carglumic acid, Folic Acid, Sapropterin dihydrochloride, Thiamine, Vitamin B6 and B12 and Vitamin D) and Distribution Channel (Hospital pharmacies, Retail pharmacies and online stores): Global Industry Perspective, Comprehensive Analysis and Forecast, 2019 – 2025”.

According to the report, global demand for Amino Acid Metabolism Disorders Treatment Market was valued at approximately USD 697.67 Million in 2018, and is expected to generate revenue of around USD 1,075.51 Million by end of 2025, growing at a CAGR of around 6.46% between 2018 and 2025.

Request Free Sample is Available @ https://www.zionmarketresearch.com/sample/amino-acid-metabolism-disorders-treat 

Amino acid is the building block which enables one’s body to make proteins.  The components found in amino acid include hydrogen (H), nitrogen (N), oxygen (O), and carbon (C), and others. Nearly 500 naturally occurring amino acids have been identified, of which only 20 are apparent in the genetic code, which can be further broken down into countless ways. At least one metabolic disorder related to amino acids. Metabolic diseases can arise when the normal metabolic process takes over from unusual chemical reactions. The case may also be that the amino acid gets into the cells. The processing of toxic material within the body is thus responsible for these problems.

The financial burden will decrease the growth in demand for amino acid metabolism disorder treatment in the coming years due to increased costs of amino acid supplements and patient noncompliance. The price in the UK is estimated to be around € 4,000 per year. In addition, lack of awareness about such conditions will have a negative effect on market growth. The industry’s growth will also have a negative impact on physiological stress, pain, inconvenience, and infection risk associated with repeated injections of phenylketonuria.

The market for Amino Acid Metabolism Disorders Treatment is segmented based on enzyme, indication, product, distribution channel, and region. Based on Indication, the market is segmented into    Argininosuccinic academia, Citrullinemia, Homocystinuria, Phenylketonuria and Maple syrup urine disease. Among those, phenylketonuria is predicted to emerge dominant by the end of the forecast period. The market is categorized into Arginine, Betaine, Carglumic Acid, Folic Acid, Sapropterin Dihydrochloride, Thiamine, Vitamin B6 and B12 and Vitamin D based on the Drug type. The carglumic acid segment will show significant growth during the forecast period. Carglumic acid is used in people with a deficiency of N-acetyl glutamate synthase to treat hyperammonemia. Each year, about 30 newborns in the U.S. were diagnosed with hyperammonemia at national health institutes, according to the United States. Increasing prevalence of hyperammonemia will fuel the carglumic acid market over the forecast period.

Based on the Distribution Channel segment, the market is bifurcated into Hospital pharmacies, Retail pharmacies and online stores. The distribution channel group for hospital pharmacies will have a significant share over the coming years. Hospital pharmacies typically store a large number of drugs and advanced equipment and provide hospital patients with medication. The burden of genetic disorder would increase the number of hospitalizations, thereby having a positive effect on hospital pharmaceutical development.

Regional segmentation includes the current and forecast demand for Asia Pacific, North America, Latin America, Europe, and Middle East & Africa with its further bifurcation into major countries. North America is expected to lead the world market over the forecast period. Countries like the United States, Germany, Spain, and France are expected to provide the players operating in this market with lucrative growth opportunities. Europe is predicted to be the second-largest country after North America. Furthermore, rising nutritional management activities in Asia Pacific offer beneficial growth prospects for this market.

Some of the players included in Amino Acid Metabolism Disorders Treatment market are AMINO GmbH, Civentichem, LLC, Koninklijke DSM N.V., Kyowa Hakko Kirin Co., Ltd, Merck KGaA and Recordati S.p.A. amongst others.

The report segments global Amino Acid Metabolism Disorders Treatment market as follows:

Global Amino Acid Metabolism Disorders Treatment MarketIndication      Segment Analysis

  • Argininosuccinic academia
  • Citrullinemia
  • Homocystinuria
  • Phenylketonuria
  • Maple syrup urine disease

Global Amino Acid Metabolism Disorders Treatment MarketProduct Segment Analysis

  • Arginine
  • Betaine
  • Carglumic acid
  • Folic Acid
  • Sapropterin dihydrochloride
  • Thiamine
  • Vitamin B6 and B12
  • Vitamin D

Global Amino Acid Metabolism Disorders Treatment MarketDistribution Channel Segment Analysis

  • Hospital pharmacies
  • Retail pharmacies
  • Online stores

 Global Amino Acid Metabolism Disorders Treatment MarketRegional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

To view TOC of this report is available upon request @ https://www.zionmarketresearch.com/toc/amino-acid-metabolism-disorders-treatment-market 



Contact Information:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com






Keywords:    Amino Acid Metabolism Disorders Treatment Market

Tags:    iCN Internal Distribution, Research Newswire, English